NEW YORK, June 13 – The life sciences division of Shimadzu has agreed to purchase Qiagen Genomics’ SNP analysis platform and license the technology, the companies said Wednesday.

The non-exclusive agreement calls for Shimadzu to purchase Qiagen Genomics’ genotyping chemistry and instrumentation for five years. Shimadzu of Japan will use the equipment to provide genotyping services to Japanese customers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.